GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at 8458.36, ...

GSK reaffirmed its 2025 outlook and said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, after ...